The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02850627
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT02850627
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02850627. Randomized; double masking; primary purpose prevention. Start 2016-07 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients
- Condition
- Coronary Heart Disease
- Condition
- Acute Myocardial Infarction
- Intervention (Drug)
- Tongguan capsule
- Intervention (Drug)
- placebo capsule
- Lead sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct02850627- Content hash
7c13f3baa23808ad5d362eb3755b7e06580b5e5c771b10bf557bf9a4bf4aee85